Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 5INDUSTRY 3NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Dermatologic 1

Conditions

Melanoma 33Neoplasms 18Colorectal Neoplasms 3Skin Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Solid Tumor 1Skin Diseases 1Neoplasms, Unknown Primary 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Diabetes Mellitus, Insulin-Dependent, 12 1Colorectal Cancer Metastatic 1Biliary Tract Neoplasms 1Advanced BRAF-mutant Cancers 1

Interventions

Bevacizumab 187Fluorouracil 150Leucovorin 135Cetuximab 127Irinotecan 114Oxaliplatin 108pembrolizumab 96Capecitabine 82IFL protocol 53Panitumumab 43Nivolumab 43regorafenib 42Folfox protocol 39Gemcitabine 30trifluridine tipiracil drug combination 27Cisplatin 24Carboplatin 24atezolizumab 23Pemetrexed 20Paclitaxel 20Drug Therapy 20130-nm albumin-bound paclitaxel 17Trastuzumab 14encorafenib 13Trifluridine 13Ipilimumab 13HMPL-013 13tislelizumab 12spartalizumab 11Docetaxel 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Colorectal Neoplasms × Vemurafenib × Clear all
NCT02291289 2024-05-06

MODUL

Hoffmann-La Roche

Phase 2 Completed
1,044 enrolled 21 charts
Gastrointestinal

Colorectal Neoplasms

NCT05233332 2023-05-31

mCRC

Shanghai Kechow Pharma, Inc.

Phase 2 Unknown
186 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00405587 2017-08-22

Safety Study of PLX4032 in Patients With Solid Tumors

Plexxikon

Phase 1 Completed
109 enrolled 39 charts
DermatologicGastrointestinal

Melanoma, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡